These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14301883)

  • 1. [SERUM ENZYME ACTIVITIES IN PROGRESSIVE MUSCULAR DYSTROPHY TREATED WITN NIVALINE OR P-ACETYLAMINOBENZILIDENE-ISONICOTINOYL HYDRAZONE].
    POPOV N; VELINOVA M
    Psychiatr Neurol Med Psychol (Leipz); 1964 May; 16():193-7. PubMed ID: 14301883
    [No Abstract]   [Full Text] [Related]  

  • 2. [STUDIES ON NIVALINE. III. ACTION OF NIVALINE ON VARIOUS BIOLOGICAL CONSTANTS (BLOOD COUNT, LIPID EXCHANGE, SERUM ALDOLASE AND TRANSAMINASES)].
    LOMBARDO G; ARENA G; LONDRILLO A
    Minerva Pediatr; 1963 Nov; 15():1357-60. PubMed ID: 14115136
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biochemical aspects of progressive muscular dystrophy. Investigations on the blood enzyme picture and behavior of some muscle enzymes in relation to the histological picture].
    COLETTA A; BERNI CANANI M; REA F; SCHETTINI F; CIGALA F
    Pediatria (Napoli); 1962; 70():779-811. PubMed ID: 14022273
    [No Abstract]   [Full Text] [Related]  

  • 4. [DIAGNOSTIC SIGNIFICANCE OF THE SERUM ALDOLASE ACTIVITY IN PROGRESSIVE MUSCULAR DYSTROPHY IN CHILDHOOD].
    WILUTZKY H
    Monatsschr Kinderheilkd (1902); 1964 Aug; 112():366-9. PubMed ID: 14259613
    [No Abstract]   [Full Text] [Related]  

  • 5. [ENZYMATIC ACTIVITY IN BLOOD IN THE COURSE OF TREATMENT WITH MONOAMINE OXIDASE INHIBITORS (NIALAMIDE) OF AGED SUBJECTS].
    NESPOLI M; ROBUSTELLIDELLACUNA G; TAMMARO AE; ACCETTURA N
    G Gerontol; 1964 Sep; 12():1091-4. PubMed ID: 14258418
    [No Abstract]   [Full Text] [Related]  

  • 6. [SERUM ENZYME CHEMISTRY IN LEUKEMIA].
    HIRAKI K; ASANO K
    Sogo Igaku; 1963 Aug; 20():575-9. PubMed ID: 14044381
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aldolase, GOT and LDH activity of the serum in progressive muscular dystrophy and myotonic dystrophy].
    CORRIDORI F; NEGRI S
    Riv Sper Freniatr Med Leg Alien Ment; 1961 Mar; 85():161-9. PubMed ID: 13881467
    [No Abstract]   [Full Text] [Related]  

  • 8. [ON THE IMPORTANCE OF ENZYMES IN DIAGNOSIS].
    TAKEDA M
    Sogo Rinsho; 1964 Jul; 13():1353-7. PubMed ID: 14176116
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of some erythrocytic enzymatic activities in subjects with progressive muscular dystrophy].
    BERNI CANANI M; COLETTA A; REA F; MASSIMO L
    Boll Soc Ital Biol Sper; 1962 Oct; 38():1022-4. PubMed ID: 13967640
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma aldolase and glutamic-oxaloacetic transaminase activities in inherited muscular dystrophy of domestic chicken.
    CORNELIUS CE; LAW GR; JULIAN LM; ASMUNDSON VS
    Proc Soc Exp Biol Med; 1959 May; 101(1):41-4. PubMed ID: 13658184
    [No Abstract]   [Full Text] [Related]  

  • 11. ALTERATIONS IN SERUM ENZYMES AFTER REPEATED EXPOSURE TO MALATHION.
    GRECH JL
    Br J Ind Med; 1965 Jan; 22(1):67-71. PubMed ID: 14261708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [STUDIES ON SERUM ENZYMES IN CHILDREN WITH PROGRESSIVE MUSCULAR DYSTROPHY].
    GRINIO LP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():961-6. PubMed ID: 14103866
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE BEHAVIOR OF SERUM ALDOLASE AND TRANSAMINASE ACTIVITY IN PROGRESSIVE MUSCULAR DYSTROPHY IN BASIC CONDITIONS AND AFTER ANABOLIC AND RE-METABOLIZING THERAPY].
    BUSCAINO GA; SEPE O
    Acta Neurol (Napoli); 1964; 19():523-46. PubMed ID: 14208396
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum ATP: creatine phosphotransferase in skeleto-muscular disorders with special reference to duchenne muscular dystrophy.
    Griffiths PD
    Guys Hosp Rep; 1965; 114(4):401-20. PubMed ID: 5859368
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum enzyme changes in muscle disease and their relation to tissue change.
    HUGHES BP
    Proc R Soc Med; 1963 Mar; 56(3):179-82. PubMed ID: 13955533
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of galantamine bromhydrate (nivaline) in the paralytic sequelae of poliomyelitis, neuraxitis and in muscular dystrophy].
    LOMBARDO G; ARENA G
    Minerva Pediatr; 1962 Jun; 14():724-8. PubMed ID: 14466410
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of serum transaminase and aldolase levels in the course of myopathy].
    BRETON A; GAUDIER B; TRAISNEL M; PONTE C
    Pediatrie; 1960; 15():19-25. PubMed ID: 13804277
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biological anomalies in the apparently healthy transmitters of muscular dystrophy].
    DEMOS J; DREYFUS JC; SCHAPIRA F; SCHAPIRA G
    Rev Can Biol; 1962; 21():587-97. PubMed ID: 14026924
    [No Abstract]   [Full Text] [Related]  

  • 19. [MUSCULAR DYSTROPHY OF THE DUCHENNE TYPE: ENZYMATIC ACTIVITY IN A FAMILIAL GROUP OF SUBJECTS WITH AND WITHOUT CLINICAL MANIFESTATIONS].
    MARZUOLI U; RUBINO R; BOCCALATTE G
    Minerva Med; 1965 Jan; 56():90-2. PubMed ID: 14248694
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood enzymes in Duchene's progressive muscular dystrophy and their correlation with the clinical and histological pictures.
    Niebrój-Dobosz I; Jedrzejowska H; Hetnarska L
    Acta Med Pol; 1970; 11(4):387-93. PubMed ID: 5493781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.